U.S. Water expands integrated offerings and applications with acquisition

Published: September 12, 2017

Tonka Water, a major supplier of municipal and industrial water treatment systems, has joined the U.S. Water family. The acquisition of Tonka Water will allow U.S. Water to expand its integrated water treatment equipment offerings and applications. Tonka Water's engineers customize water treatment solutions for a variety of applications including surface water, groundwater, water reuse, industrial process water, remediation and advanced wastewater treatment. “The addition of Tonka Water to the U.S. Water family strengthens our engineering and equipment capabilities and the integrated solutions we can offer our customers throughout the market,” said LaMarr Barnes, U.S. Water CEO. “We are very excited to welcome Tonka Water. Their experienced and customer-focused employees will be a great addition to our team.”

New Investment in UK’s Cell and Gene Therapy Catapult

Published: September 11, 2017

£12m Industrial Strategy Challenge Fund award will double current capacity of the Cell and Gene Therapy Catapult Manufacturing Centre in Stevenage, Hertfordshire (UK), enabling more companies to develop cell therapy products for the global market. As part of a £197 million investment in the healthcare and life sciences sector, a £12 million award from the UK Government’s Industrial Strategy Challenge Fund will significantly increase the current size and capability of the Cell and Gene Therapy Catapult (CGT Catapult) large-scale GMP Manufacturing Centre in Stevenage, Hertfordshire, UK. The award, which builds on the current £55 million investment in the project, allows the Centre’s capacity to double, offering businesses developing cell therapy products further opportunities to accelerate trials and worldwide commercialization to bring these rapidly evolving medicines to patients.

Cambrex invests in new lab at High Point

Published: September 11, 2017

Cambrex is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq ft analytical laboratory. The investment comes in response to growing customer demand for analytical development and validation services in support of cGMP products at the clinical stage. Installation of equipment, including HPLCs, mass spectrometers and support equipment, will commence in Q3 2017, with validation and start up anticipated in Q4 2017. As a result of the expansion, Cambrex will add twelve new analytical development scientists to the R&D team. The laboratory will be used to broaden analytical support for customer projects at the High Point site, and forms part of a strategic plan to support Cambrex’s global analytical development and method validation needs.

PCI Pharma Services expands cold chain capacity

Published: September 11, 2017

PCI Pharma Services has announced the investment in a considerable expansion of its onsite cold chain storage at its Philadelphia site. PCI announced an additional 500 pallet spaces have been added, increasing its onsite 2-8°C refrigerated storage to more than 1,300 pallets. The 450,000 square foot site features contract packaging services for over-the-counter medicines, ethical pharmaceuticals and medical devices, as well as animal health therapies. The cold chain expansion supports PCI’s growing presence in Biotech medicines.

Clintec expands HQ and receives Queens Award for Enterprise

Published: September 11, 2017

Clintec, the global full service CRO, has been presented with the Queens Award for Enterprise 2017, in the category of International Trade - by Lord Provost, Eva Bolander in her capacity as Lord Lieutenant. The award coincides with the official opening of an additional floor at Clintec’s Glasgow-based headquarters.

Published: August 29, 2017



Copyright © 2017 Mack Brooks Speciality Publishing.